stockrowGeron Corporation (GERN) vs Zevra Therapeutics, Inc. (ZVRA)
- Geron Corporation GERN 0.98 +3.16%
- Zevra Therapeutics, Inc. ZVRA 11.55 +9.69%
Geron Corporation and Zevra Therapeutics, Inc. are both Biotechnology companies. Geron Corporation and Zevra Therapeutics, Inc. are of similar size ($626.6M and $610.4M). Geron Corporation has negative trailing earnings, so its P/E is not meaningful; Zevra Therapeutics, Inc. trades at 9.0×. Zevra Therapeutics, Inc. grew revenue faster over the last twelve months: 75.1% against 18.6%. Zevra Therapeutics, Inc. has the higher net margin (50.7% vs −22.0%) and the higher return on invested capital (129.5% vs −34.1%). Across the 18 metrics below, Zevra Therapeutics, Inc. leads on 13 and Geron Corporation on 5.
Valuation
Profitability
| Metric | GERN | ZVRA | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.59% | 95.44% | 68.51% |
| Operating margin | (14.75%) | 60.78% | 0.00% |
| Net margin | (21.99%) | 50.73% | 0.00% |
| Free cash flow margin | (41.91%) | 58.93% | 0.00% |
| Return on equity | (20.12%) | 40.29% | (51.96%) |
| Return on assets | (8.74%) | 25.69% | (46.06%) |
| Return on invested capital | (34.12%) | 129.48% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack